MedTrace Logo

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer

NCT03121469 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2026-01-23

No results posted yet for this study

Summary

Phase 1/2 study, open, monocenter, non-randomized

Conditions

  • Localized Breast Cancer

Interventions

DEVICE

Papillon +TM

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM

Sponsors & Collaborators

  • Centre Antoine Lacassagne

    lead OTHER

Principal Investigators

  • Christine LOVERA, MRS · Centre Antoine Lacassagne

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-25
Primary Completion
2020-11-30
Completion
2025-06-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03121469 on ClinicalTrials.gov